Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 2Tuberculosis, Pulmonary 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pneumonia 1Osteosarcoma 1Motor Activity 1Lung Injury 1Hypoxia 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Thoracotomy × Clear all
NCT03786003 2023-07-21

ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)

Fudan University

Phase NA Recruiting
1,086 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02360761 2016-09-20

STEPS

Peking University People's Hospital

Phase 3 Unknown
339 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡